Erratum: The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated mice (Molecular Therapy (2013) 21 (348-357) DOI: 10.1038/mt.2012.204)

Diana M. Rommelfanger, Marta C. Grau, Rosa M. Diaz, Elizabeth Ilett, Luis Alvarez-Vallina, Jill M. Thompson, Timothy J. Kottke, Alan Melcher, Richard G. Vile

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)913
Number of pages1
JournalMolecular Therapy
Issue number4
StatePublished - Apr 2013

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this